慢性鼻窦炎伴鼻息肉鼻黏膜中纤维蛋白交联和降解相关调控基因表达异常

doi:10.3969/j.issn.1006-7795.2024.02.012

首都医科大学学报 ›› 2024, Vol. 45 ›› Issue (2): 246-251.doi: 10.3969/j.issn.1006-7795.2024.02.012

• 慢性鼻窦炎机制和临床研究 • 上一篇下一篇

慢性鼻窦炎伴鼻息肉鼻黏膜中纤维蛋白交联和降解相关调控基因表达异常

王明^1，2, 洪宇^1，2, 卜祥婷^1，2, 王成硕^1,2*#, 张罗^1,2*#

1.首都医科大学附属北京同仁医院耳鼻咽喉头颈外科、过敏科，北京 100730； 2. 北京市耳鼻咽喉科研究所,北京市中西医结合耳鼻咽喉科研究所，过敏性疾病北京实验室（北京市教育委员会）、鼻病研究北京市重点实验室、耳鼻咽喉头颈科学教育部重点实验室（首都医科大学），北京100005

收稿日期:2024-01-18 出版日期:2024-04-21 发布日期:2024-04-25
通讯作者: 王成硕, 张罗 E-mail:wangcs830@126.com, dr.luozhang@139.com
基金资助:
国家重点研发计划项目(2022YFC2504100)，国家自然科学基金项目(82171109, 82025010)，北京市属医学科研院所公益发展改革试点项目(JYY2023-1)。

Dysregulation of genes related to fibrin formation and degradation in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps

Wang Ming^1，2, Hong Yu^1，2, Bu Xiangting^1，2, Wang Chengshuo^1，2*#, Zhang Luo^1，2*#

1.Department of Otorhinolaryngology Head and Neck Surgery and Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; 2. Beijing Institute of Otolaryngology, Beijing Institute of Integrated Traditional Chinese and Western Medicine in Otolaryngology, Beijing Laboratory of Allergic Diseases （Beijing Municipal Education Commission）, Beijing Key Laboratory of Nasal Diseases, Key Laboratory of Otolaryngology Head and Neck Surgery (Capital Medical University)，Ministry of Education,, Beijing 100005, China

Received:2024-01-18 Online:2024-04-21 Published:2024-04-25
Supported by:
This work was supported by National Key R&D Program of China (2022YFC2504100), the National Natural Science Foundation of China (82171109, 82025010), Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes (JYY2023-1).

摘要/Abstract

摘要： 目的研究慢性鼻窦炎伴鼻息肉（chronic rhinosinusitis with nasal polyps，CRSwNP）患者以及合并哮喘（asthma，AS）患者（CRSwNP+AS）鼻黏膜中纤维蛋白沉积及其相关调控基因的表达情况。方法利用免疫荧光染色评估鼻黏膜中纤维蛋白的沉积情况；利用实时荧光定量聚合酶链式反应检测纤维蛋白交联和降解相关调控基因的表达，以及糖皮质激素治疗后的基因表达变化。结果与对照组相比，CRSwNP鼻黏膜中有显著的纤维蛋白沉积，且呈交联状态，CRSwNP+AS组有更明显的纤维蛋白沉积。基因表达检测显示，促进纤维蛋白交联的基因-凝血因子ⅩⅢ A1（factor ⅩⅢ A chain 1, F13A1）和抑制纤维蛋白降解的基因-纤溶酶原激活物抑制物1（plasminogen activator inhibitor 1, PAI-1）在CRSwNP和CRSwNP+AS组的表达均升高，并且F13A1在CRSwNP+AS组的表达较CRSwNP显著更高；促进纤维蛋白降解的基因-组织型纤溶酶原激活因子（plasminogen activator tissue type, PLAT）在CRSwNP+AS组的表达显著低于CRSwNP和对照组；尿激酶型纤溶酶原激活因子（plasminogen activator urokinase, PLAU）的表达在两种类型的CRSwNP中均上调。CRSwNP+AS患者经糖皮质激素治疗，可显著下调F13A1、上调PLAT的表达。结论 CRSwNP患者鼻黏膜中存在大量纤维蛋白沉积，可能与纤维蛋白交联和降解相关基因的表达失调有关，合并AS患者鼻黏膜中F13A1和PLAT的表达失调更为明显。

关键词: 慢性鼻窦炎伴鼻息肉, 哮喘, 纤维蛋白, 凝血因子ⅩⅢ A, 纤溶酶原激活因子

Abstract: Objective To explore the deposition of fibrin and the expression of genes related to fibrin formation and degradation in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and patients with CRSwNP comorbid asthma (CRSwNP+AS). Methods Immunofluorescence staining was used to evaluate the deposition of fibrin in the nasal mucosa. Real-time fluorescence quantitative polymerse chain reaction (RT-qPCR) was used to detect the expression of genes related to fibrin formation and degradation ［factor ⅩⅢ A chain 1 (F13A1)， plasminogen (PLG)， plasminogen activator tissue type (PLAT)， plasminogen activator urokinase (PLAU) and plasminogen activator inhibitor 1 (PAI-1)］ in nasal mucosa of CRSwNP, CRSwNP+AS and control subjects. The patients received glucocorticoid treatment. Results Compared with the control group, immunofluorescence staining showed obvious deposition of crosslinked fibrin in the nasal mucosa of patients with CRSwNP, and CRSwNP+AS group had more significant fibrin deposition. Gene expression analysis showed that the expression of F13A1, a gene that promotes fibrin formation, and PAI-1, a gene that inhibits fibrin degradation, were both significantly increased in the CRSwNP and CRSwNP+AS groups. In addition, the expression of F13A1 was significantly higher in CRSwNP+AS group than that in CRSwNP group. The expression of PLAT, which promotes fibrin degradation, was significantly lower in the CRSwNP+AS group than that in the CRSwNP and control groups. PLAU is upregulated in both types of CRSwNP. Glucocorticoid treatment significantly downregulates F13A1 and upregulates the expression of PLAT in patients with CRSwNP+AS. Conclusion Patients with CRSwNP have excessive fibrin deposition in the nasal mucosa, which may be caused by the dysregulation of genes related to fibrin formation and degradation. Dysregulated F13A1 and PLAT were more significant in CRSwNP+AS.

Key words: chronic rhinosinusitis with nasal polyps, asthma, fibrin, factor ⅩⅢ A, plasminogen activator

中图分类号:

R765

王明, 洪宇, 卜祥婷, 王成硕, 张罗. 慢性鼻窦炎伴鼻息肉鼻黏膜中纤维蛋白交联和降解相关调控基因表达异常[J]. 首都医科大学学报, 2024, 45(2): 246-251.

Wang Ming, Hong Yu, Bu Xiangting, Wang Chengshuo, Zhang Luo. Dysregulation of genes related to fibrin formation and degradation in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps[J]. Journal of Capital Medical University, 2024, 45(2): 246-251.

参考文献

［1］ Fokkens W J, Lund V J, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020［J］. Rhinology, 2020, 58(Suppl 29): 1-464.
［2］ Huang K W, Yang T, Xu J Y, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study［J］. Lancet, 2019, 394(10196): 407-418.
［3］ Benjamin M R, Stevens W W, Li N, et al. Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting［J］. J Allergy Clin Immunol Pract, 2019, 7(3): 1010-1016.
［4］ Won H K, Kim Y C, Kang M G, et al. Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset［J］. Ann Allergy Asthma Immunol, 2018, 120(4): 389-394.
［5］ Takabayashi T, Schleimer R P. Formation of nasal polyps: the roles of innate type 2 inflammation and deposition of fibrin［J］. J Allergy Clin Immunol, 2020, 145(3): 740-750.
［6］ Bu X T, Wang M, Luan G, et al. Integrated miRNA and mRNA expression profiling reveals dysregulated miRNA-mRNA regulatory networks in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps［J］. Int Forum Allergy Rhinol, 2021, 11(8): 1207-1219.
［7］ Striz I, Golebski K, Strizova Z, et al. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis［J］. Clin Sci (Lond), 2023, 137(9): 727-753.
［8］ Brescia G, Alessandrini L, Zanotti C, et al. Histopathological and hematological changes in recurrent nasal polyposis［J］. Int Forum Allergy Rhinol, 2019, 9(7): 813-820.
［9］ Castillo J A, Plaza V, Rodrigo G, et al. Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma［J］. J Allergy Clin Immunol Glob, 2023, 2(4): 100134.
［10］ Sella G C P, Tamashiro E, Sella J A, et al. Asthma is the dominant factor for recurrence in chronic rhinosinusitis［J］. J Allergy Clin Immunol Pract, 2020, 8(1): 302-309.
［11］ Tiotiu A, Novakova P, Guillermo G, et al. Management of adult asthma and chronic rhinitis as one airway disease［J］. Expert Rev Respir Med, 2021, 15(9): 1135-1147.
［12］ Wang M, Bu X T, Luan G, et al. Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma［J］. Clin Transl Allergy, 2020, 10: 26.
［13］ Matucci A, Bormioli S, Nencini F, et al. Asthma and chronic rhinosinusitis: how similar are they in pathogenesis and treatment responses?［J］. Int J Mol Sci, 2021, 22(7): 3340.
［14］ Chen C L, Yao Y, Pan L, et al. Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes［J］. J Allergy Clin Immunol, 2020, 146(3): 677-681.
［15］ Zhu Y L, Esnault S, Ge Y, et al. Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling［J］. Clin Proteomics, 2022, 19(1): 15.
［16］ Heissig B, Salama Y, Takahashi S, et al. The multifaceted role of plasminogen in inflammation［J］. Cell Signal, 2020, 75: 109761.
［17］ Takabayashi T, Kato A, Peters A T, et al. Increased expression of factor ⅩⅢ-a in patients with chronic rhinosinusitis with nasal polyps［J］. J Allergy Clin Immunol, 2013, 132(3): 584-592.e4.
［18］ Jo A, Choi T G, Han J Y, et al. Age-related increase of collagen/fibrin deposition and high PAI-1 production in human nasal polyps［J］. Front Pharmacol, 2022, 13: 845324.
［19］ De Lorenzi V, Sarra Ferraris G M, Madsen J B, et al. Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin［J］. EMBO Rep, 2016, 17(7): 982-998.
［20］ Hopkins C. Chronic rhinosinusitis with nasal polyps［J］. N Engl J Med, 2019, 381(1): 55-63.

[1]	孟海洋, 王敏, 李颖, 王向东, 张罗. 地塞米松体外对鼻息肉趋化因子生成的影响[J]. 首都医科大学学报, 0, (): 233-238.
[2]	杨婧兴, 赵妍, 陈陆泉, 蔡超, 王向东. 基于网络药理学探究黄芩治疗慢性鼻窦炎的潜在作用机制[J]. 首都医科大学学报, 0, (): 252-261.
[3]	郑铭, 吴健有, 司马宇彤, 王向东, 张罗. 有/无鼻窦炎症状的牙源性鼻窦炎患者的临床特征比较[J]. 首都医科大学学报, 2024, 45(2): 239-245.
[4]	冯颖, 时克, 王宪波. 肝硬化合并肠系膜上静脉栓塞患者2年预后预测模型的构建与验证[J]. 首都医科大学学报, 2023, 44(1): 107-114.
[5]	李艳, 王麒淇, 张宇玲, 段甦, 张海波, 王向东, 蓝凤. 不同体质量指数的慢性鼻窦炎伴鼻息肉患者临床特征分析[J]. 首都医科大学学报, 2022, 43(6): 899-904.
[6]	杨婧兴, 蔡超, 赵妍, 王向东, 张罗. 黄芩苷在呼吸道黏膜慢性炎症性疾病中的抗炎作用及机制研究进展[J]. 首都医科大学学报, 2022, 43(6): 919-923.
[7]	王麒淇, 蓝凤, 王晶, 郝柳思琪, 李艳, 张罗. PCDH9影响过敏性鼻炎鼻黏膜上皮屏障功能的体外研究[J]. 首都医科大学学报, 0, (): 886-892.
[8]	赵之玥, 张罗. 胸怀祖国放眼世界,探索慢性鼻病奥秘——张罗教授[J]. 首都医科大学学报, 2020, 41(5): 742-747.
[9]	王敏, 李颖, 王向东, 张罗. IL-23在慢性鼻窦炎中的表达和作用[J]. 首都医科大学学报, 2020, 41(2): 178-182.
[10]	王明, 卜祥婷, 栾格, 王阳, 王成硕, 张罗. MALAT1在慢性鼻窦炎伴鼻息肉中的表达及对糖皮质激素治疗的反应性[J]. 首都医科大学学报, 2020, 41(2): 183-188.
[11]	杜崑, 郑铭, 王向东, 张罗. 白细胞介素-21与复发性鼻息肉组织中IgE的相关性分析[J]. 首都医科大学学报, 2020, 41(2): 194-199.
[12]	张鹏, 杨威, 王奎吉, 谭翊, 商晓娟, 舒凝, 汪芗, 许世闻, 孙三峰, 赵新雨, 於堃, 陈陆泉. 针刺蝶腭神经节治疗变应性鼻炎的多中心病例系列研究[J]. 首都医科大学学报, 2019, 40(6): 916-920.
[13]	孟祥龙, 海涌, 杨晋才, 苏庆军. 颈椎动态稳定器治疗单节段颈椎病的回顾性研究[J]. 首都医科大学学报, 2019, 40(1): 124-128.
[14]	许庆庆, 段甦, 王向东, 张罗. 鼻中隔偏曲矫正对变应性鼻炎患者治疗效果的Meta分析[J]. 首都医科大学学报, 2018, 39(6): 928-932.
[15]	高占梅, 宋扬, 刘华, 文昌隆, 孙海洋. 氮卓斯汀鼻喷剂联合地氯雷他定治疗变应性鼻炎疗效的Meta分析[J]. 首都医科大学学报, 2018, 39(3): 458-464.

慢性鼻窦炎伴鼻息肉鼻黏膜中纤维蛋白交联和降解相关调控基因表达异常

Dysregulation of genes related to fibrin formation and degradation in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价